XT
TSHA icon

XTX Topco’s Taysha Gene Therapies TSHA Stock Holding History

XTX Topco’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.2K Buy
+10,329
New +$48K ﹤0.01% 3343
2025
Q3 		– Sell
-320,737
Closed -$741K – 3296
2025
Q2 		$741K Buy
320,737
+117,608
+58% +$256K 0.03% 844
2025
Q1 		$282K Buy
+203,129
New +$340K 0.01% 1454
2024
Q2 		– Sell
-41,052
Closed -$118K – 2477
2024
Q1 		$118K Buy
41,052
+24,767
+152% +$51.6K 0.02% 1330
2023
Q4 		$28.8K Buy
+16,285
New +$32.5K 0.01% 1316
2023
Q2 		– Sell
-85,167
Closed -$67.9K – 1855
2023
Q1 		$67.9K Buy
+85,167
New +$110K 0.01% 1137

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco's TSHA Position: Q1 2026 in Review

XTX Topco opened a new position in Taysha Gene Therapies (TSHA) in Q1 2026: 10,329 shares worth $46.2K. The stake represents ﹤0.01% of the portfolio and ranks #3343 among its holdings. This is a return to the name: XTX Topco previously reported a position in TSHA as recently as Q2 2025.

XTX Topco first reported a position in TSHA in Q1 2023 and has held it in 6 quarters since. The position peaked at $741K in Q2 2025. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

  • XTX Topco held 10,329 shares of Taysha Gene Therapies worth $46.2K as of Q1 2026.
  • Taysha Gene Therapies was a new XTX Topco position in Q1 2026.
  • Taysha Gene Therapies made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3343 holding.
  • XTX Topco first reported a position in Taysha Gene Therapies in Q1 2023 and has held it in 6 quarters since.
  • XTX Topco's Taysha Gene Therapies position peaked at $741K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.